Literature DB >> 11559694

Essential hypertension: the heart and hypertension.

K E Berkin1, S G Ball.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11559694      PMCID： PMC1729925          DOI： 10.1136/heart.86.4.467

Source DB:  PubMed          Journal:  Heart        ISSN： 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  23 in total

1.  State of the Art lecture. Risk mechanisms in hypertensive heart disease.

Authors:  E D Frohlich
Journal:  Hypertension       Date:  1999-10       Impact factor: 10.190

2.  Diagnosing primary diastolic heart failure.

Authors:  D L Brutsaert
Journal:  Eur Heart J       Date:  2000-01       Impact factor: 29.983

3.  Blood pressure and the risk of cardiovascular disease.

Authors:  S MacMahon
Journal:  N Engl J Med       Date:  2000-01-06       Impact factor: 91.245

4.  Left ventricular hypertrophy in hypertension.

Authors:  F G Dunn; M A Pfeffer
Journal:  N Engl J Med       Date:  1999-04-22       Impact factor: 91.245

5.  Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial.

Authors:  L Hansson; L H Lindholm; L Niskanen; J Lanke; T Hedner; A Niklason; K Luomanmäki; B Dahlöf; U de Faire; C Mörlin; B E Karlberg; P O Wester; J E Björck
Journal:  Lancet       Date:  1999-02-20       Impact factor: 79.321

6.  Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study.

Authors:  L Hansson; L H Lindholm; T Ekbom; B Dahlöf; J Lanke; B Scherstén; P O Wester; T Hedner; U de Faire
Journal:  Lancet       Date:  1999-11-20       Impact factor: 79.321

7.  Association of aortic-valve sclerosis with cardiovascular mortality and morbidity in the elderly.

Authors:  C M Otto; B K Lind; D W Kitzman; B J Gersh; D S Siscovick
Journal:  N Engl J Med       Date:  1999-07-15       Impact factor: 91.245

8.  The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators.

Authors:  B Pitt; F Zannad; W J Remme; R Cody; A Castaigne; A Perez; J Palensky; J Wittes
Journal:  N Engl J Med       Date:  1999-09-02       Impact factor: 91.245

Review 9.  Guidelines for management of hypertension: report of the third working party of the British Hypertension Society.

Authors:  L Ramsay; B Williams; G Johnston; G MacGregor; L Poston; J Potter; N Poulter; G Russell
Journal:  J Hum Hypertens       Date:  1999-09       Impact factor: 3.012

10.  Survival in treated hypertension: follow up study after two decades.

Authors:  O K Andersson; T Almgren; B Persson; O Samuelsson; T Hedner; L Wilhelmsen
Journal:  BMJ       Date:  1998-07-18
View more
  10 in total

1.  Transforming growth factor-beta(1) expression in dilated cardiomyopathy.

Authors:  J E Sanderson; K B Lai; I O Shum; S Wei; L T Chow
Journal:  Heart       Date:  2001-12       Impact factor: 5.994

2.  Idiopathic dilated cardiomyopathy: lack of association with haemochromatosis gene in the CARDIGENE study.

Authors:  G Hetet; B Grandchamp; C Bouchier; V Nicaud; L Tiret; G Roizès; M Desnos; K Schwartz; R Dorent; M Komajda
Journal:  Heart       Date:  2001-12       Impact factor: 5.994

3.  Contrast enhanced magnetic resonance angiography and pulmonary venous anomalies.

Authors:  F Godart; S Willoteaux; C Rey; B Cocheteux; C Francart; J P Beregi
Journal:  Heart       Date:  2001-12       Impact factor: 5.994

4.  Effects of cardiac resynchronisation on maximal and submaximal exercise performance in advanced heart failure patients with conduction abnormality.

Authors:  D Birnie; L P Soucie; S Smith; A S Tang
Journal:  Heart       Date:  2001-12       Impact factor: 5.994

5.  Reciprocal increase of circulating interleukin-10 and interleukin-6 in patients with acute myocardial infarction.

Authors:  N Kotajima; T Kimura; T Kanda; A Kuwabara; Y Fukumura; M Murakami; I Kobayashi
Journal:  Heart       Date:  2001-12       Impact factor: 5.994

6.  Percutaneous aortic valve replacement: will we get there?

Authors:  Y Boudjemline; P Bonhoeffer
Journal:  Heart       Date:  2001-12       Impact factor: 5.994

7.  Tetrahydrobiopterin attenuates cholesterol induced coronary hyperreactivity to endothelin.

Authors:  S Verma; A S Dumont; A Maitland
Journal:  Heart       Date:  2001-12       Impact factor: 5.994

8.  Comparative pharmacology of human beta-adrenergic receptor subtypes--characterization of stably transfected receptors in CHO cells.

Authors:  C Hoffmann; M R Leitz; S Oberdorf-Maass; M J Lohse; K-N Klotz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2004-01-17       Impact factor: 3.000

9.  Combined effects of cigarette smoking, alcohol drinking and eNOS Glu298Asp polymorphism on blood pressure in Chinese male hypertensive subjects.

Authors:  Zhe Hong; Liying Pan; Zhangqing Ma; Yue Zhu; Zongyuan Hong
Journal:  Tob Induc Dis       Date:  2019-08-02       Impact factor: 2.600

10.  Metabolomics of Artichoke Bud Extract in Spontaneously Hypertensive Rats.

Authors:  Zhi-Bin Wang; Shi-Long Jiang; Shao-Bo Liu; Jing-Bo Peng; Shuo Hu; Xu Wang; Wei Zhuo; Tong Liu; Ji-Wei Guo; Hong-Hao Zhou; Zhi-Quan Yang; Xiao-Yuan Mao; Zhao-Qian Liu
Journal:  ACS Omega       Date:  2021-07-12
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.